HOXA5 and type 2 diabetes mellitus: To test this hypothesis, we adopted bisulfite sequencing and analyzed DNA methylation levels at the HOXA5 promoter, comparatively, in preadipocytes from individuals who were FDR of type 2 diabetics and in those who had no diabetes familiarity.